RBC on Boston Scientific (BSX) Long-Range Plan Released Earlier at Investor Day, 'we are encouraged
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
JPMorgan on Boston Scientific (BSX) Investor Day Update: 'reinforces our bullish view on Boston'
September 20, 2023 10:52 AM EDTJPMorgan analyst Robbie Marcus reiterated an Overweight rating on Boston Scientific (NYSE: BSX)
The analyst comments "Management kicked off the Boston Scientific biennial analyst day with an update to its LRP (long range plan) for 2024-2026 that now points towards: (1) sales CAGR of +8-10%... More
AutoZone, Starbucks and Block fall premarket; Dell, Tesla rise
September 19, 2023 8:04 AM EDTInvesting.com -- U.S. futures traded marginally higher Tuesday, as investors await the start of the crucial two-day Federal Reserve meeting, which could set the tone for weeks to come.
Here are some of the biggest premarket U.S. stock movers today:
Instacart is set to make its Nasdaq... More
Boston Scientific (BSX) to Acquire Relievant Medsystems for Over $850 Million
September 19, 2023 7:01 AM EDTBoston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept® Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain. The transaction includes an upfront cash payment of $850 million and undisclosed additional contingent payments based on sales performance over the next three... More
